MiMedx Group, Inc. is a therapeutic biologics company, which engages in the design, manufacture, and marketing of products, and tissue processing services. It serves the wound care, burn, surgical, orthopedic, spine, sports medicine, ophthalmic, and dental sectors of healthcare. Its biomaterial platform technologies include AmnioFix and EpiFix, a tissue allografts derived from amnion and chorion layers of human placental membrane, EpiCord and AmnioCord, a tissue allografts derived from umbilical cord tissue, and AmnioFill, a placental connective tissue matrix derived from the placental disc and other placental tissue. The company was founded on July 30, 1985 and is headquartered in Marietta, GA.
Hand & UpperEx Center, Wexford, Pennsylvania, United States
Central Research Associates, Inc, Birmingham, Alabama, United States
Southeastern Center for Clinical Trials, Atlanta, Georgia, United States
Weil Foot, Ankle and Orthopedic Institute, Des Plaines, Illinois, United States
Shepherd Spine Center, Atlanta, Georgia, United States
Costal Podiatry, Virginia Beach, Virginia, United States
ILD Research, Carlsbad, California, United States
Ambulatory Foot & Ankle Center, PC, Hampton, Virginia, United States
Weil Foot, Ankle and Orthopedic Institute, Des Plaines, Illinois, United States
Central Research Associates, Inc, Birmingham, Alabama, United States
Bruce Cairns Surgery Burn Center, Chapel Hill, North Carolina, United States
Arizona Burn Center, Phoenix, Arizona, United States
University of San Diego Nedical Center, San Diego, California, United States
Professional Education and Research Institute, Roanoke, Virginia, United States
The Mayer Institute, Hamilton, Ontario, Canada
Florida Hospital: Global Robotics Institute, Celebration, Florida, United States
Southern Arizona VA Health Care System, Tucson, Arizona, United States
James A. Lovell Federal Health Care Center, North Chicago, Illinois, United States
Scott & White Healthcare, Temple, Texas, United States